India to Belgium: Gemcitabine Export Trade Route

The India to Belgium Gemcitabine corridor is one of India's established pharmaceutical export routes, with 140 shipments documented worth a combined $5.9M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 76% of all export value, reflecting the consolidated nature of India's gemcitabine manufacturing sector.

Across 5 active suppliers, the average shipment value stands at $42.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with gemcitabine's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 26.5%, placing it at rank #2 among India's top gemcitabine export destinations globally.

On the import side, key buyers of Indian gemcitabine in Belgium include YUSEN LOGISTICS BENELUX BELGIUM, YUSEN LOGISTICS BENELUX BELGIUM , YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN and 4 others. YUSEN LOGISTICS BENELUX BELGIUM is the single largest importer with 88 shipments valued at $4.0M USD.

India's gemcitabine exports to Belgium are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 100 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Belgium benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED — together account for 99% of total trade value on this route. The average shipment value of $42.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as gemcitabine sun ppf1200mg/120ml1s pu it and gemcitabine ppf 1800mg/180ml (gemcitabin, suggesting that buyers in Belgium tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, YUSEN LOGISTICS BENELUX BELGIUM is the largest importer with 88 shipments worth $4.0M USD — representing 68% of all gemcitabine imports from India on this route. A total of 7 buyers are active on this corridor.